首页> 外文期刊>Bioorganic and medicinal chemistry >13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation.
【24h】

13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation.

机译:(20S)-1α,25-二羟基-2-亚甲基-19-正维生素D3(2MD)的13-甲基取代的des-C,D类似物:合成和生物学评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D(3) (2, 2MD), substituted at C-13 but lacking both C and D rings, were prepared in convergent syntheses, starting with the chiral ester 14 and the phosphine oxide 29. Two of the synthesized vitamins (11 and 32) were analogs in which the 13-methyl group constituted a substituent of an unsaturated fragment, that is, C(13)-C(17) double bond, whereas in the two other cases (12 and 13), the methyl group belonged to a ternary carbon stereogenic center. The aim of these studies was to further explore extensive modifications in the 'upper' part of the vitamin D skeleton in the hope of finding biologically active analogs of potential therapeutic value. The commercial (R)-(-)-methyl-3-hydroxy-2-methylpropionate (14) was converted in six steps to alcohol 18, the vitamin D side chain fragment. Its subsequent three-step transformation led to aldehyde 20 which was subjected to the Still-Gennari HWE reaction with anion derived from ester 21. The obtainedalpha,beta-unsaturated esters 22 and 23 served as convenient starting compounds to the syntheses of the corresponding chiral acyclic aldehydes, beta,gamma-unsaturated (28) and saturated (39 and 40), required for the final Wittig-Horner coupling with the anion of the phosphine oxide 29. After hydroxyl deprotection, the synthesized vitamin D analogs 11-13 and 32 were purified and biologically tested. Only the (13R,20S)-analog 12 retained substantial, although 30 times lower than 1alpha,25-(OH)(2)D(3), binding ability to the full-length rat recombinant vitamin D receptor (VDR). This analog was also very effective in differentiation of HL-60 cells, and it exerted significant transcriptional activity (2 times and 15 times less potent, respectively, as compared to the native hormone). The in vivo tests showed that all synthesized vitamin D analogs were devoid of calcemic activity.
机译:从会聚的合成开始,制备(20S)-1α,25-二羟基-2-亚甲基-19-诺维他命D(3)(2,2MD)在C-13处同时缺少C和D环的类似物。分别是手性酯14和氧化膦29。两种合成的维生素(11和32)是类似物,其中13-甲基构成不饱和片段的取代基,即C(13)-C(17)双键,而在其他两种情况(12和13)中,甲基属于三元碳立体异构中心。这些研究的目的是进一步探索维生素D骨架“上部”的广泛修饰,以期找到具有潜在治疗价值的生物活性类似物。将商品(R)-(-)-甲基-3-羟基-2-甲基丙酸酯(14)分六步转化为维生素D侧链片段醇18。其随后的三步转化产生醛20,使其与酯21衍生的阴离子进行Still-Gennari HWE反应。获得的α,β-不饱和酯22和23用作合成相应手性无环化合物的方便的起始化合物。最终的Wittig-Horner与氧化膦29的阴离子偶联所需要的醛,β,γ-不饱和醛(28)和饱和(39和40)。在羟基脱保护后,合成的维生素D类似物11-13和32为纯化并经过生物学测试。尽管只有(13R,20S)-analog 12与1alpha,25-(OH)(2)D(3)的结合能力比全长大鼠重组维生素D受体(VDR)低30倍,但仍保持了相当高的水平。该类似物在HL-60细胞的分化中也非常有效,并且发挥了显着的转录活性(与天然激素相比,效力分别降低了2倍和15倍)。体内试验表明,所有合成的维生素D类似物都没有钙化活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号